Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California, USA.
Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
J Leukoc Biol. 2019 Jun;105(6):1209-1224. doi: 10.1002/JLB.1VMA0818-320R. Epub 2019 Feb 12.
Neutrophil chemotaxis is essential in responses to infection and underlies inflammation. In neutrophils, the small GTPase Rac1 has discrete functions at both the leading edge and in the retraction of the trailing structure at the cell's rear (uropod), but how Rac1 is regulated at the uropod is unknown. Here, we identified a mechanism mediated by the trafficking protein synaptotagmin-like 1 (SYTL1 or JFC1) that controls Rac1-GTP recycling from the uropod and promotes directional migration of neutrophils. JFC1-null neutrophils displayed defective polarization and impaired directional migration to N-formyl-methionine-leucyl-phenylalanine in vitro, but chemoattractant-induced actin remodeling, calcium signaling and Erk activation were normal in these cells. Defective chemotaxis was not explained by impaired azurophilic granule exocytosis associated with JFC1 deficiency. Mechanistically, we show that active Rac1 localizes at dynamic vesicles where endogenous JFC1 colocalizes with Rac1-GTP. Super-resolution microscopy (STORM) analysis shows adjacent distribution of JFC1 and Rac1-GTP, which increases upon activation. JFC1 interacts with Rac1-GTP in a Rab27a-independent manner to regulate Rac1-GTP trafficking. JFC1-null cells exhibited Rac1-GTP accumulation at the uropod and increased tail length, and Rac1-GTP uropod accumulation was recapitulated by inhibition of ROCK or by interference with microtubule remodeling. In vivo, neutrophil dynamic studies in mixed bone marrow chimeric mice show that JFC1 neutrophils are unable to move directionally toward the source of the chemoattractant, supporting the notion that JFC1 deficiency results in defective neutrophil migration. Our results suggest that defective Rac1-GTP recycling from the uropod affects directionality and highlight JFC1-mediated Rac1 trafficking as a potential target to regulate chemotaxis in inflammation and immunity.
中性粒细胞趋化作用对于感染反应和炎症基础至关重要。在中性粒细胞中,小分子 GTP 酶 Rac1 在细胞前缘的延伸和尾部结构(尾足)的回缩中具有不同的功能,但 Rac1 在尾足处是如何被调节的尚不清楚。在这里,我们发现了一种由 trafficking 蛋白 synaptotagmin-like 1(SYTL1 或 JFC1)介导的机制,该机制控制 Rac1-GTP 从尾足的再循环,并促进中性粒细胞的定向迁移。JFC1 缺失的中性粒细胞在体外表现出极化缺陷和定向迁移到 N-甲酰基-甲硫氨酸-亮氨酸-苯丙氨酸的能力受损,但这些细胞中的趋化因子诱导的肌动蛋白重塑、钙信号和 Erk 激活是正常的。JFC1 缺失与 JFC1 缺陷相关的嗜苯胺颗粒胞吐作用受损无关,这不能解释缺陷的趋化作用。从机制上讲,我们表明活性 Rac1 定位于含有内源性 JFC1 的动态囊泡处,与 Rac1-GTP 共定位。超分辨率显微镜(STORM)分析显示 JFC1 和 Rac1-GTP 的相邻分布,在激活时增加。JFC1 以 Rab27a 独立的方式与 Rac1-GTP 相互作用,以调节 Rac1-GTP 转运。JFC1 缺失细胞表现出 Rac1-GTP 在尾足处的积累和尾部长度的增加,并且 ROCK 抑制或微管重塑干扰可再现 Rac1-GTP 尾足积累。在体内,混合骨髓嵌合小鼠中性粒细胞动态研究表明,JFC1 中性粒细胞无法朝趋化因子的来源方向定向移动,这支持了 JFC1 缺失导致中性粒细胞迁移缺陷的观点。我们的结果表明,从尾足处 Rac1-GTP 的再循环缺陷会影响方向性,并强调 JFC1 介导的 Rac1 转运作为调节炎症和免疫中趋化作用的潜在靶点。